Total Funding
37
26
Total FundingVenture - Series Unknown raised
Growth Score 37 in past quarter
-3 pts
Heat Score 26 in past quarter
4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
454492
Strategic Science & Technologies focuses on commercializing a novel, patented transdermal administration formula.
Steven Brugger: DirectorPast Role: Momenta Pharmaceuticals, Chief Operating Officer
About the Company
Strategic Science & Technologies is a privately-held technology company that focuses on commercializing a novel, patented transdermal administration formula. Its technology is used to formulate known pharmaceutical active ingredients that have a faster onset of action, delivers molecules across the skin in therapeutic areas including pain, and
treat sexual disorders that enable physicians to treat various diseases with the support of technology.
